Journal of Alzheimer's & Dementia Open Access

Calcium Dysregulation and Synaptic Destabilization

Ethan Rios^* Department of Neurophysiology, Lakewood University, Toronto, Canada
^*Correspondence: Ethan Rios, Department of Neurophysiology, Lakewood University, Toronto, Canada, Email:

Received: 17-Nov-2025, Manuscript No. IPAD-25-23847; Editor assigned: 20-Nov-2025, Pre QC No. IPAD-25-23847 (PQ); Reviewed: 04-Dec-2025, QC No. IPAD-25-23847; Revised: 11-Dec-2025, Manuscript No. IPAD-25-23847 (R); Published: 18-Dec-2025, DOI: 10.36648/ipad.25.8.80

Description

Calcium ions play a central role in synaptic transmission, plasticity and signaling. Dysregulation of calcium homeostasis disrupts synaptic function, impairing neurotransmitter release, receptor activation and intracellular signaling pathways. Both excessive and insufficient calcium signaling negatively affect presynaptic and postsynaptic compartments, reducing synaptic adaptability and destabilizing networks [1]. Calcium influx triggers neurotransmitter release at presynaptic terminals. Impaired voltage-gated calcium channel function or altered intracellular calcium buffering reduces vesicle fusion efficiency, leading to diminished signal propagation. Postsynaptic calcium signals regulate receptor trafficking, kinase activation and gene expression critical for synaptic plasticity. Dysregulated calcium impairs these processes, limiting the capacity for long-term potentiation and memory formation [2].

Mitochondria act as calcium buffers at synapses. Dysfunctional mitochondria fail to sequester excess calcium, increasing cytosolic concentrations and triggering excitotoxicity. Excess calcium activates proteases, phospholipases and apoptotic pathways, damaging synaptic structures. Maintaining mitochondrial health and calcium buffering capacity preserves synaptic signaling and structural integrity. Endoplasmic reticulum stores also regulate calcium availability [3,4]. Disruption of Endoplasmic Reticulum (ER) calcium homeostasis impairs local signaling, receptor trafficking and vesicle recycling. ER stress induces unfolded protein responses that interfere with synaptic function and plasticity. Interventions supporting ER function and calcium regulation protect synaptic efficacy. Glial cells contribute to calcium regulation at synapses. Astrocytes buffer extracellular calcium and modulate neurotransmitter release, while microglia respond to calcium-dependent signaling during injury or stress. Dysregulated glial activity amplifies calcium disturbances, further destabilizing synaptic networks.

Environmental and metabolic factors influence calcium homeostasis. Chronic stress, toxins or nutrient deficiencies affect channel function, buffering capacity and intracellular signaling, impairing synaptic stability. Lifestyle interventions supporting cardiovascular and metabolic health improve calcium regulation and synaptic function [5-7]. Pharmacological approaches targeting calcium signaling restore synaptic efficacy. Agents modulating channel function, buffering capacity or downstream signaling improve neurotransmitter release, receptor function and plasticity. Combined with metabolic support and lifestyle interventions, these strategies maintain synaptic stability and enhance cognitive performance [8]. Calcium dysregulation has been strongly linked to disorders such as Alzheimer’s disease, Parkinson’s disease and Huntington’s disease. In these conditions, abnormal protein aggregates and cellular stress disrupt calcium signaling pathways. For example, in Alzheimer’s disease, amyloid-beta peptides can form channels in neuronal membranes, allowing uncontrolled calcium entry. This disrupts synaptic function early in the disease process, even before significant neuronal loss occurs. Similarly, dopaminergic neurons in Parkinson’s disease are particularly susceptible to calcium-induced stress due to their reliance on calcium-dependent pacemaking activity [9].

The destabilization of synapses has far-reaching consequences for brain function. Synaptic integrity is essential for maintaining neural circuits that underlie cognition, emotion and behavior. Loss or dysfunction of synapses leads to impaired signal transmission and network disorganization. Importantly, research has shown that synaptic loss correlates more strongly with cognitive decline than neuronal death itself, highlighting the central role of synaptic health in neurological conditions [10].

Conclusion

In conclusion, calcium dysregulation is a critical factor in synaptic destabilization and the progression of neurological disorders. The precise regulation of calcium is essential for maintaining synaptic structure, function and plasticity. When this balance is disrupted, it initiates a cascade of damaging events that compromise neuronal communication and viability. Understanding the mechanisms of calcium dysregulation provides valuable insights into potential therapeutic approaches aimed at preserving synaptic stability and preventing neurodegeneration.

References

1. Stutzmann GE (2007). The pathogenesis of Alzheimers disease—is it a lifelong “Calciumopathy”?. The Neurosci. 13(5):546-559.

   [Google Scholar] [CrossRef] [PubMed]

2. Selkoe DJ (2002). Alzheimer's disease is a synaptic failure. Sci. 298(5594):789-791.

   [Google Scholar] [CrossRef] [PubMed]

3. DeKosky ST, Scheff SW (1990). Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27(5):457-464..

   [Google Scholar] [CrossRef] [PubMed]

4. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R,et.al. (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 30(4):572-580.

   [Google Scholar] [CrossRef] [PubMed]

5. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G,et.al. ( 1999). Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models. PNAS. 96(6):3228-3233.

   [Google Scholar] [CrossRef] [PubMed]

6. Moyer Jr JR, Furtak SC, McGann JP, Brown TH (2011). Aging-related changes in calcium-binding proteins in rat perirhinal cortex. Neurobiol Aging. 32(9):1693-706.

   [Google Scholar] [CrossRef] [PubMed]

7. Oh MM, Oliveira FA, Waters J, Disterhoft JF (2013). Altered calcium metabolism in aging CA1 hippocampal pyramidal neurons. J Neurosci.33(18):7905-7911.

   [Google Scholar] [CrossRef] [PubMed]

8. Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu HY, Hyman BT,et.al. (2008). Aβ plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron.59(2):214-225.

   [Google Scholar] [CrossRef] [PubMed]

9. Gauthier S, Loft H, Cummings J (2008). Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis. Int J Geriatr Psychiatry. 23(5):537-545.

   [Google Scholar] [CrossRef] [PubMed]

10. Copenhaver PF, Anekonda TS, Musashe D, Robinson KM, Ramaker JM,et.al. (2011). A translational continuum of model systems for evaluating treatment strategies in Alzheimer’s disease: isradipine as a candidate drug. DMM. 4(5):634-648.

    [Google Scholar] [CrossRef] [PubMed]